Editorial: ICRF-187 As a Cardioprotectant in Children Treated with Anthracyclines
- 1 January 1997
- journal article
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 14 (3)
- https://doi.org/10.3109/08880019709009486
Abstract
(1997). Editorial: ICRF-187 As a Cardioprotectant in Children Treated with Anthracyclines. Pediatric Hematology and Oncology: Vol. 14, No. 3, pp. iii-vi.Keywords
This publication has 5 references indexed in Scilit:
- Use of ICRF-187 for Prevention of Anthracycline Cardiotoxicity in Children: Preliminary ResultsPediatric Hematology and Oncology, 1997
- Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin.Journal of Clinical Oncology, 1996
- The dioxopiperazine derivatives, their leukemogenic potential and other biological effectsLeukemia Research, 1992
- Phase II trial of ICRF-187 in children with solid tumors and acute leukemiaInvestigational New Drugs, 1991
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerNew England Journal of Medicine, 1988